B. Sassolas

6.0k total citations · 1 hit paper
101 papers, 2.8k citations indexed

About

B. Sassolas is a scholar working on Dermatology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, B. Sassolas has authored 101 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Dermatology, 22 papers in Oncology and 19 papers in Pathology and Forensic Medicine. Recurrent topics in B. Sassolas's work include Cutaneous Melanoma Detection and Management (19 papers), Autoimmune Bullous Skin Diseases (15 papers) and Urticaria and Related Conditions (13 papers). B. Sassolas is often cited by papers focused on Cutaneous Melanoma Detection and Management (19 papers), Autoimmune Bullous Skin Diseases (15 papers) and Urticaria and Related Conditions (13 papers). B. Sassolas collaborates with scholars based in France, Germany and United States. B. Sassolas's co-authors include Maja Mockenhaupt, Jean Claude Roujeau, Peggy Sekula, Ariane Dunant, J.C. Roujeau, Jean‐Paul Fagot, Cynthia Haddad, Dieter Vieluf, Hervé Le Louët and Konrad Bork and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and CHEST Journal.

In The Last Decade

B. Sassolas

95 papers receiving 2.7k citations

Hit Papers

ALDEN, an Algorithm for Assessment of Drug Causality in S... 2010 2026 2015 2020 2010 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis
    2010 474 citations B. Sassolas, Cynthia Haddad et al. Clinical Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Sassolas France 25 1.1k 895 893 718 530 101 2.8k
Hong‐Shang Hong Taiwan 19 988 0.9× 513 0.6× 605 0.7× 693 1.0× 318 0.6× 67 2.4k
L. Valeyrie‐Allanore France 32 2.8k 2.6× 2.1k 2.3× 1.3k 1.4× 869 1.2× 137 0.3× 104 4.4k
Joung-Liang Lan Taiwan 17 746 0.7× 1.9k 2.2× 487 0.5× 193 0.3× 204 0.4× 24 3.2k
Osvaldo Correia Portugal 23 2.0k 1.8× 1.0k 1.1× 942 1.1× 1.1k 1.5× 241 0.5× 56 2.9k
Martine Bagot France 38 323 0.3× 630 0.7× 1.7k 2.0× 2.4k 3.4× 883 1.7× 183 4.9k
Andrea Matucci Italy 32 434 0.4× 675 0.8× 197 0.2× 309 0.4× 185 0.3× 114 3.2k
M.‐S. Doutre France 20 284 0.3× 479 0.5× 437 0.5× 405 0.6× 66 0.1× 131 1.4k
M. Viguier France 27 102 0.1× 489 0.5× 519 0.6× 729 1.0× 879 1.7× 125 3.0k
Sinisa Savic United Kingdom 33 281 0.3× 649 0.7× 168 0.2× 240 0.3× 182 0.3× 142 3.1k
Morton Scheinberg Brazil 29 137 0.1× 1.5k 1.6× 315 0.4× 146 0.2× 283 0.5× 155 3.1k

Countries citing papers authored by B. Sassolas

Since Specialization
Citations

This map shows the geographic impact of B. Sassolas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Sassolas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Sassolas more than expected).

Fields of papers citing papers by B. Sassolas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Sassolas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Sassolas. The network helps show where B. Sassolas may publish in the future.

Co-authorship network of co-authors of B. Sassolas

This figure shows the co-authorship network connecting the top 25 collaborators of B. Sassolas. A scholar is included among the top collaborators of B. Sassolas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Sassolas. B. Sassolas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Senet, Patricia, H. Maillard, Élisabeth Diot, et al.. (2022). Efficacy and Safety of Botulinum Toxin in Adults with Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Study. Arthritis & Rheumatology. 75(3). 459–467. 5 indexed citations
2.
Staumont‐Sallé, D., M. Tauber, C. Paul, et al.. (2020). De novo psoriasis in atopic dermatitis patients treated with dupilumab: a retrospective cohort. Journal of the European Academy of Dermatology and Venereology. 35(4). e296–e297. 27 indexed citations
3.
Phan, C., Alain Beauchet, J. Mazereeuw‐Hautier, et al.. (2019). Evaluation of Children with Psoriasis from the BiPe Cohort: Are Patients Using Biotherapies in Real Life Eligible for Phase III Clinical Studies?. Pediatric Drugs. 21(3). 169–175. 6 indexed citations
4.
5.
Bidre, E. Le, G. Chaby, Ludovic Martin, et al.. (2011). Pelade au cours d’un traitement par anti-TNF alpha : neuf cas. Annales de Dermatologie et de Vénéréologie. 138(4). 285–293. 18 indexed citations
6.
Sassolas, B., Cynthia Haddad, Maja Mockenhaupt, et al.. (2010). ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis. Clinical Pharmacology & Therapeutics. 88(1). 60–68. 474 indexed citations breakdown →
7.
Peuvrel, L., et al.. (2009). Impact of a campaign to train general practitioners in screening for melanoma. European Journal of Cancer Prevention. 18(3). 225–229. 13 indexed citations
8.
Humbert, Patrick O., et al.. (2006). Ulcères de jambe présentant des signes locaux d'infection : Intérêt du pansement Biatain® argent. 52(52). 41–47. 1 indexed citations
9.
Gréco, M., et al.. (2006). Syndrome d’hypersensibilité médicamenteuse à l’Hexaquine® (quinine et thiamine). Annales de Dermatologie et de Vénéréologie. 133(4). 354–358. 4 indexed citations
10.
Valentin, Simon, et al.. (2006). Mélanome malin achromique : à propos de trois cas. Annales de Chirurgie Plastique Esthétique. 52(1). 68–70. 1 indexed citations
11.
Piette, F, Philippe Blanc, Laurent Mortier, et al.. (2005). Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans. British Journal of Dermatology. 153(5). 932–936. 52 indexed citations
12.
Legoupil, Délphine, et al.. (2005). Évaluation d’une consultation d’urgences en dermatologie. Annales de Dermatologie et de Vénéréologie. 132(11). 857–859. 13 indexed citations
13.
Joly, P., Jacques Bénichou, Catherine Lok, et al.. (2005). Prediction of Survival for Patients With Bullous Pemphigoid. Archives of Dermatology. 141(6). 691–8. 109 indexed citations
14.
Leroy, J.P., et al.. (2005). Dermatose neutrophilique associée à des anticorps anticytoplasme des polynucléaires neutrophiles (p-ANCA) induits par le propylthiouracil. Annales de Dermatologie et de Vénéréologie. 132(1). 27–31. 12 indexed citations
15.
Quinio, Dorothée, et al.. (2004). Zygomycosis caused byCunninghamella bertholletiaein a kidney transplant recipient. Medical Mycology. 42(2). 177–180. 38 indexed citations
16.
Douet‐Guilbert, Nathalie, et al.. (2004). Rearrangement of MLL in a patient with congenital acute monoblastic leukemia and granulocytic sarcoma associated with a t(1;11)(p36;q23) translocation. Leukemia & lymphoma. 46(1). 143–146. 18 indexed citations
17.
Kupfer, I., et al.. (2004). Corticosteroid Treatment for Melanoma-Associated Retinopathy. Archives of Dermatology. 140(10). 1258–61. 19 indexed citations
18.
Guillot, B., S. Dalac, M. Delaunay, et al.. (2004). Cutaneous malignant melanoma and neurofibromatosis type 1. Melanoma Research. 14(2). 159–163. 41 indexed citations
19.
Grob, Jean‐Jacques, Brigitte Dréno, Pauline de La Salmonière, et al.. (1998). Randomised trial of interferon α-2a as adjuvant therapy in resected primary melanoma thicker than 1·5 mm without clinically detectable node metastases. The Lancet. 351(9120). 1905–1910. 274 indexed citations
20.
Guillet, G., R. Hélénon, Yvon Gauthier, et al.. (1988). Progressive macular hypomelanosis of the trunk: primary acquired hypopigmentation. Journal of Cutaneous Pathology. 15(5). 286–289. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong‐Shang Hong Breakdown of academic impact, for papers by L. Valeyrie‐Allanore Breakdown of academic impact, for papers by Joung-Liang Lan Breakdown of academic impact, for papers by Osvaldo Correia Breakdown of academic impact, for papers by Martine Bagot Breakdown of academic impact, for papers by Andrea Matucci Breakdown of academic impact, for papers by M.‐S. Doutre Breakdown of academic impact, for papers by M. Viguier Breakdown of academic impact, for papers by Sinisa Savic Breakdown of academic impact, for papers by Morton Scheinberg
Rankless by CCL
2026